Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases

被引:88
|
作者
Chen, Ruochan [1 ,2 ,3 ]
Hou, Wen [1 ]
Zhang, Qiuhong [1 ]
Kang, Rui [1 ]
Fan, Xue-Gong [2 ,3 ]
Tang, Daolin [1 ]
机构
[1] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA
[2] Cent South Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, State Key Lab Viral Hepatitis, Changsha, Hunan, Peoples R China
基金
美国国家卫生研究院;
关键词
ISCHEMIA-REPERFUSION INJURY; HEPATIC ISCHEMIA/REPERFUSION INJURY; CHROMATIN PROTEIN HMGB1; END-PRODUCTS RAGE; RECEPTOR; HEPATOCELLULAR-CARCINOMA; LETHAL SEPSIS; CLINICOPATHOLOGICAL FEATURES; STERILE INFLAMMATION; THERAPEUTIC TARGET;
D O I
10.2119/molmed.2013.00099
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Damage-associated molecular pattern (DAMP) molecules are essential for the initiation of innate inflammatory responses to infection and injury. The prototypic DAMP molecule, high-mobility group box 1 (HMGB1), is an abundant architectural chromosomal protein that has location-specific biological functions: within the nucleus as a DNA chaperone, within the cytosol to sustain autophagy and outside the cell as a DAMP molecule. Recent research indicates that aberrant activation of HMGB1 signaling can promote the onset of inflammatory and autoimmune diseases, raising interest in the development of therapeutic strategies to control their function. The importance of HMGB1 activation in various forms of liver disease in relation to liver damage, steatosis, inflammation, fibrosis, tumorigenesis and regeneration is discussed in this review.
引用
收藏
页码:357 / 366
页数:10
相关论文
共 50 条
  • [1] Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
    Ruochan Chen
    Wen Hou
    Qiuhong Zhang
    Rui Kang
    Xue-Gong Fan
    Daolin Tang
    Molecular Medicine, 2013, 19 : 357 - 366
  • [2] The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma
    Shim, E. -J.
    Chun, E.
    Lee, H. -S.
    Bang, B. -R.
    Kim, T. -W.
    Cho, S. -H.
    Min, K. -U.
    Park, H. -W.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (06): : 958 - 965
  • [3] The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
    Chen, Qingjie
    Guan, Xiaofeng
    Zuo, Xiaocong
    Wang, Jianglin
    Yin, Wenjun
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (03) : 183 - 188
  • [4] The role of high mobility group box 1(HMGB1)in the pathogenesis of kidney diseases
    Qingjie Chen
    Xiaofeng Guan
    Xiaocong Zuo
    Jianglin Wang
    Wenjun Yin
    Acta Pharmaceutica Sinica B, 2016, 6 (03) : 183 - 188
  • [5] Role of High-Mobility Group Box 1 (HMGB1) in Transplantation of Rat Pancreatic Islets
    Jeong, Seonghee
    Lee, Song
    Mee-Lee, Chan
    Shim, In Kyong
    Kim, Song-Cheol
    ANNALS OF TRANSPLANTATION, 2017, 22 : 121 - 127
  • [6] High-mobility group box 1 (HMGB1) protein: Friend and foe
    Ulloa, Luis
    Messmer, Davorka
    CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (03) : 189 - 201
  • [7] High-mobility group box 1 (HMGB1) crosses the BBB bidirectionally
    Banks, William A.
    Hansen, Kim M.
    Erickson, Michelle A.
    Crews, Fulton T.
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 111 : 386 - 394
  • [8] High mobility group box 1 (HMGB1)
    Yang, H
    Tracey, KJ
    CRITICAL CARE MEDICINE, 2005, 33 (12) : S472 - S474
  • [9] High-mobility group box 1 (HMGB1) in childhood: from bench to bedside
    Chirico, Valeria
    Lacquaniti, Antonio
    Salpietro, Vincenzo
    Munafo, Caterina
    Calabro, Maria Pia
    Buemi, Michele
    Arrigo, Teresa
    Salpietro, Carmelo
    EUROPEAN JOURNAL OF PEDIATRICS, 2014, 173 (09) : 1123 - 1136
  • [10] High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
    Castiglioni, Alessandra
    Canti, Valentina
    Rovere-Querini, Patrizia
    Manfredi, Angelo A.
    CELL AND TISSUE RESEARCH, 2011, 343 (01) : 189 - 199